LifeStrands Genomics (Australia) Pty Ltd

Site

LifeStrands Genomics

Accreditation No.

21166

Site No.

25462

Date of Accreditation

03 May 2023

Address

Building A (G.01), 18-24 Ricketts Road
Mount Waverley, VIC 3149
Australia

Contact

Dr Lynn Fink P: +61 (03) 75037791

Availability

Services available to external clients

Supervision

GX (General)

LifeStrands Genomics (Australia) Pty Ltd address map

Scope of Accreditation

Print scopes
LifeStrands Genomics

ISO 15189 (2022)

  • This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.

Human Pathology

Service Product Determinant
Molecular genetics - DNA extraction Blood Viable DNA for sequencing and other molecular assays
Cytology samples; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue Viable DNA for sequencing and other molecular assays
Molecular genetics - Detection and characterisation of cell free RNA (cfRNA) and/or cell free DNA (cfDNA) and/or cell free TNA (cfTNA) and/or circulating tumour DNA (ctDNA) in cancer screening and/or cancer genetic testing Blood; Body fluids; Extracted DNA; Liquid biopsy; Plasma Copy number variation (CNV); Exon skipping; Gene fusion; Indels; Nucleic acid analysis for specific variants; Single nucleotide variants (SNVs); Solid tumours
Blood; Body fluids; Extracted RNA; Liquid biopsy; Plasma Copy number variation (CNV); Exon skipping; Gene fusion; Indels; Nucleic acid analysis for specific variants; Single nucleotide variants (SNVs); Solid tumours
Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted panels for non-inherited (somatic) DNA/RNA changes Extracted DNA MLH1 promoter methylation analysis
Copy number variation (CNV); Somatic mutation detection
Homologous recombination deficiency (HRD)
Copy number variation (CNV); Microsatellite instability analysis; Somatic mutation detection
MGMT promoter methylation analysis
Extracted DNA; Extracted RNA Copy number variation (CNV); Gene fusion; Microsatellite instability analysis; Somatic mutation detection; Tumour mutation burden (TMB)
Copy number variation (CNV); Gene fusion; Somatic mutation detection
Extracted RNA Gene fusion; Somatic mutation detection
Molecular genetics - Investigation of constitutional genetic variants - Diagnostic testing - Targeted panels for inherited (germline) DNA/RNA changes Extracted DNA Inherited cancer syndromes; Solid tumours
Molecular genetics - RNA extraction Blood Viable RNA for molecular diagnostics; Viable RNA for sequencing
Cytology samples; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues Viable RNA for molecular diagnostics; Viable RNA for sequencing
Viable RNA for molecular diagnostics; Viable RNA for sequencing
Molecular genetics - Screening for an unknown mutation - Targeted panels for non-inherited (somatic) DNA/RNA changes Cytology samples; Formalin-fixed paraffin-embedded (FFPE) tissues; Tissues Solid tumours
Molecular genetics and/or cytogenetics - Bioinformatic analysis DNA sequences; FASTQ files Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation
DNA sequences; FASTQ files; RNA sequences; VCF files Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation

The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.

Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.